News items related to: News
-
Ever-greening Patents – a Common Trick of Big Pharma, and Access to MDR TB Drug in Thailand
Chalermsak Kittitrakul, TNP+’s Project Manager for Access to Medicines, said, “The civil society’s movement on opposing the patent applications for...
-
GSIPA2M 2025 Highlights
Dive into three days of resistance, solidarity, and vision for the global fight for access to medicines. Click on the...
-
A Tribute to Courage and Justice: Honoring Professor Hakima Himmich at the GSIPA2M 2025
With emotion palpable in the air, Moroccan journalist Amine Boushaba opened the tribute by recalling his personal journey as an...
-
Marrakech to Host Critical Global Summit on Intellectual Property and Access to Medicines — TRIPS@30: The Access Crisis
Organized by ITPC Global and the Make Medicines Affordable consortium, the summit takes place at a moment of historic urgency:...
-
TNP+ is Successfully Opposing Big Pharma’s Hepatitis C Drug Monopoly
This win comes after years of campaigning by the AIDS Access Foundation (AAF) and the Thai Network of People Living...
-
Lenacapavir Patent Faces Opposition at the Eurasian Patent Office
“If Gilead Science’s patent application regarding Lenacapavir is granted, the patent will represent another significant barrier to the affordable access...
-
Major Win: First Batch of Dolutegravir Arrives in Colombia Under a Compulsory License
The World Health Organization (WHO) recommends dolutegravir as the first- and second-line treatment for all population groups. In Colombia, access...
-
ITPC-EECA Challenges Patents on core DR-TB Drug Pretomanid, Urging Eurasian Patent Office to Protect Access
According to WHO, 400,000 people developed DR-TB in 2023, yet only 44% (175, 923) of them were treated for it....
-
Ukrainian Patient Rights Group Opposes a Patent Applications on a Life-Saving HIV Drug
Rilpivirine, commonly known as RPV, is available in multiple formulations, including a daily oral medication, and in fixed-dose combination tablets,...
-
Civil Society Groups Unite to Monitor the 4th Round of Thailand-EU FTA Negotiation
Grave concerns over expensive medicines, the universal health coverage scheme at risk, unsafe second-hand medical devices, farmers’ increasing debts &...
-
MMA Partner VNP+ Opposes Patent Application Which Would Limit Access to Long-Acting Cabotegravir
Vietnam’s Network of People Living With HIV (VNP+), a Make Medicines Affordable (MMA) partner, is working to improve access to, and affordability...
-
Thai HIV Advocacy Group Challenges Gilead’s and Janssen’s Patent Extension Bid, Citing Evergreening Tactics
The Thai Network of People Living with HIV/AIDS (TNP+) filed an opposition to a patent application filed by the U.S.-based pharmaceutical giant...